COPE Advertising options


http://immunospot.com/index.php?id=233 Cell Sciences Inc http://www.promokine.info/products/cytokines-growth-factors/cytokines-growth-factors-soluble-receptors/animal-free-endotoxin-free-cytokines-growth-factors/

COPE Homepage Bottom of page Previous entry:
thyroblasts
Next entry:
thyroid acinar cells
Random entry:
YadA(ent)
Search COPE:

Please donate

If you find COPE helpful,
please show your appreciation
by donating what you can afford.

thyrocytes

The spherical follicles (acini) of the thyroid gland absorb iodine. These follicles consist of a single continuous layer of thyrocytes (thyroid epithelial cells, thyroid follicular cells, thyroid acinar cells). There are two types of thyroid epithelial cells. Follicular cells are derived from foregut endoderm. Another type is of neuroectoderma origin (see: C-cells). Thyroblasts are fetal thyroid germ cells.

Thyrocytes secrete the thyroid hormones thyroxine (T4) and triiodothyronine (T3). The production of these hormones is under the control of the pituitary hormone TSH (thyroid stimulating hormone).

Many studies have been carried out with the rat thyroid epithelial cell line FRTL-5, which grows in continuous culture, is still differentiated, and non-tumorigenic and is assumed to be a good in vitro equivalent of thyroid follicular cells Ambesi-Impiombato and Villone, 1987). Thyrocytes have been shown to possess the capacity to express the proteins listed below. Please note the following general observations, which practically apply to all cell types: expression may be influenced by tissue localization, may occur only in discrete subpopulations of cells, may vary between established cell lines, primary cells, embryonic cells, mature cells, fully differentiated cells, activated cells, non-activated cells or growth conditions (confluent vs. sparse cultures), may be influenced by various disease states (including cancer environment), and may differ between species.
Note also: expression profile information lists entities only for which there is an entry in COPE or one of its subdictionaries.

The meaning of and is as follows: factor/protein is expressed; receptor (or, in some instances, binding sites) for this factor/protein is expressed. For further explanations concerning format, "hidden" information, and/or ambiguities see my remarks in the entry cell types.


ANF (Atrial natriuretic factor, natriuretic peptide, atrionatriuretic factor, Alpha-ANP, Atrial natriuretic polypeptide, ANP, Atrial polypeptide, Atriopeptin, cardionatrin, cardionatrin I, NPPA) receptors (Ahren, 1990; Sellitti et al, 2002)
angiopoietin-1 (Ang-1, ANGPT1, KIAA0003) (Mitsutake et al, 2002)
angiopoietin-1 (Ang-1, ANGPT1, KIAA0003) receptors (TIE-2, TEK, tunica endothelial kinase, tunica interna endothelial cell kinase, CD202, CD202B) (Cocks et al, 2000; Mitsutake et al, 2002)
angiopoietin-2 (Ang-2, ANGPT2) receptors (TIE-2, TEK, tunica endothelial kinase, tunica interna endothelial cell kinase, CD202, CD202B) (Cocks et al, 2000; Mitsutake et al, 2002)
Angiopoietin-3 (Ang-3, ANGPT3, ANGPTL1, Angiopoietin-like-1, Angioarrestin, ARP-1, angiopoietin-related protein-1) receptors (TIE-2, TEK, tunica endothelial kinase, tunica interna endothelial cell kinase, CD202, CD202B) (Cocks et al, 2000; Mitsutake et al, 2002)

bFGF (basic fibroblast growth factor, FGF basic, FGF-2, Fibroblast growth factor-2, FGF-beta, Fibroblast growth factor-beta, HBGF-2, heparin binding growth factor-2) (Cocks et al, 2000; Logan et al, 1992)
bFGF (basic fibroblast growth factor, FGF basic, FGF-2, Fibroblast growth factor-2, FGF-beta, Fibroblast growth factor-beta, HBGF-2, heparin binding growth factor-2) receptors (Cocks et al, 2000; Emoto et al, 1991; Logan et al, 1992)

CCL2 (CC chemokine ligand 2, chemokine (C-C motif) ligand 2, GDCF, Glioma-derived monocyte chemotactic factor-2, GDCF-2, HC11, JE, LDCF, MCAF, MCP, monocyte chemoattractant protein, MCP-1, monocyte chemoattractant protein-1, SMC-CF, smooth muscle cell chemotactic factor, TDCF, tumor-derived chemotactic factors, TSG-8, tumor necrosis factor-stimulated gene sequence-8, SCYA2) (Borrello et al, 2005; Goulvestre et al, 2002; Kasai et al, 1996; Kemp et al, 2003; Matsumara et al, 1999)
CCL3 (CC chemokine ligand 3, chemokine (C-C motif) ligand 3, MIP-1-alpha, macrophage inflammatory protein-1-alpha, 464.1, GOS-19-1, L2G25B, LD78, LD78-alpha, SCI, stem cell inhibition factor, stem cell inhibitor, TY5, SCYA3, SCYA3L1) (Kemp et al, 2003)
CCL4 (CC chemokine ligand 4, chemokine (C-C motif) ligand 4, SCYA4, ACT-2, Immune activation gene-2, 744.1, G26, H400, HC21, Cytokine 21, human, LAG-1, lymphocyte activation gene-1, MIP-1-beta, macrophage inflammatory protein-1-beta, SIS-gamma) (Kemp et al, 2003)
CCL5 (CC chemokine ligand 5, chemokine (C-C motif) ligand 5, RANTES, EoCP-1, Eosinophil chemotactic polypeptide-1, SIS-delta, TCP228, T-cell-specific protein p228, SCYA5) (Garcia-Lopez et al, 2001; Gianoukakis et al, 2006; Goulvestre et al, 2002; Kemp et al, 2003)
CCL20 (CC chemokine ligand 20, chemokine (C-C motif) ligand 20, SCYA20, LARC, Liver and Activation Regulated Chemokine, Exodus, Exodus-1, MIP-3-alpha, macrophage inflammatory protein-3-alpha, Ck-beta-4, Chemokine-beta-4, ST38) (Borrello et al, 2005)
CCR1 (CC-Chemokine receptor 1, RANTES receptor, MIP-1-alpha receptor, LD78 receptor, CC-CKR1, HM145, YT4, CD191, CMKBR1, chemokine-beta receptor 1) (Borrello et al, 2005)
CD26 (1F7, 2B9, 5F8, ACT-3, ADABP, ADA binding protein, ADCP2, adenosine deaminase complexing protein 2, BT5/9, DPCR1, DPP4, dipeptidyl peptidase 4, HAM.4, intestinal dipeptidyl peptidase, EC3.4.14.5, OX61, TA1, TA5/9, THAM, thymocyte-activating molecule, TP103, WC10 antigen, FAP-beta, Fibroblast activation protein-beta) (Borrello et al, 2005)
CD29 (FNRB, fibronectin receptor beta chain, ITGB1, integrin-beta-1, platelet protein GPIIa, VLA-beta, very late activation antigen-beta, VLA-beta-1, VLA-4 beta subunit) (Dahlman et al, 1998)
CD32 (hFcRII, Fc-gamma R2, FCG2, FCGR2, CD32a, CD32b, FCGR2A, Fc-gamma R2a, FCGR2B, Fc-gamma R2b, IGFR2, immunoglobulin G Fc receptor 2) (Estienne et al, 2002)
CD40 (Bp50, TNFRSF5, TNF receptor superfamily member 5) (Faure et al, 1997; Li et al, 2001; Metcalfe et al, 1998; Mukai et al, 2005)
CD44 (CDw44, CD44H, CD44A, CD44s, CD44st, CD44std, AnWj blood group antigen, ECMR-3, extracellular matrix receptor-3, class 3 ECMR, gp85, HCAM, homing-associated cell adhesion molecule, Hermes-1, Hermes antigen, HUTCH-1, Indian blood group antigen, In blood group antigen, Ly24, MC56, MDU2, MDU3, MIC4, MUC 2-63, OX49, PGP1, PGP1.1, phagocytic glycoprotein-1, GM35 antigen) (Borrello et al, 2005)
CD46 (gp45-70, HuLy-m5, MCP, membrane cofactor protein, measles virus receptor, MIC10, TLX, TRA-2-10, trophoblast-leukocyte common antigen, trophoblast-lymphocyte cross-reactive antigen) (Yamakawa et al, 1994)
CD49c (CSAT antigen band 2 protein, FRP-2, fusion regulatory protein-2, GAP-B3, galactoprotein B3, ITGA3, integrin-alpha-3, MSK18, VLA-3, very late activation antigen 3, ECMR-1, Extracellular matrix receptor-1, class 1 ECMR, VLA-alpha 3, very late activation antigen alpha-3, VLAA3, VLA-3 receptor alpha 3 subunit) (Dahlman et al, 1998)
CD49e (fibronectin receptor alpha chain, FNRA, ITGA5, integrin-alpha-5, ECMR-6, Extracellular matrix receptor-6, class 6 ECMR, GPIc, platelet glycoprotein Ic, VLA-alpha 5, very late activation antigen alpha-5, VLA-5, very late activation antigen 5, VLA-5-alpha) (Claisse et al, 1999)
CD54 (7F7, BB2, human rhinovirus receptor, ICAM-1, intercellular adhesion molecule 1, IFN-gamma regulated human melanoma-associated antigen, Ly47, MALA-2, Me14-D12, P3.58) (Borrello et al, 2005; Martin et al, 1990; Matsuoka et al, 1996; Sharma et al, 2005; Tandon et al, 1992; You et al, 1999)
CD55 (CD55a, CD55b, complement decay-accelerating factor, decay-accelerating factor, DAF, DAF-GPI, DAF-TM, GPI-DAF, TM-DAF, DAF1, decay-accelerating factor 1, DAF2, decay-accelerating factor 2, Cromer blood group antigen) (Nakai et al, 1992; Yamakawa et al, 1994)
CD56 (5.1.H11, BASCA, brain-associated small cell lung cancer antigen, Leu19, MSK39, NCAM, neural cell adhesion molecule, NCAM1, neural cell adhesion molecule-1, NCAM-120, neural cell adhesion molecule-120, NCAM-140, neural cell adhesion molecule-140, NCAM-180, neural cell adhesion molecule-180, NKH-1, PSA-NCAM, polysialylated NCAM, E-NCAM, embryonic NCAM, embryonic neural cell adhesion molecule) (Borrello et al, 2005; Migita et al, 1991)
CD58 (LFA-3, lymphocyte function-associated antigen-3, T11TS, T11 target structure) (Matsuoka et al, 1996; Tandon et al, 1992)
CD59 (CD59a, protectin, MIC11, MIN2, MIN3, MSK21, HRF20, homologous restriction factor-20 kDa, MACIF, membrane attack complex inhibitory factor, MAC-IP, MAC-inhibitory protein, H19, MIRL, membrane inhibitor of reactive lysis, P18, 1F5, 16.3A5, BRIC 229, YTH 53.1) (Nakai et al, 1992; Tandon et al, 1992; Yamakawa et al, 1994)
CD61 (CD61A, F4, F11, GPIIb/IIIa, HPA-1, human platelet antigen-1, HPA-4, human platelet antigen-4, ITGB3, integrin-beta-3, Pen alloantigen, Pen(a), Pen(b), PL(A1), platelet fibrinogen receptor beta subunit, platelet glycoprotein IIIa, GP3A, Yuk alloantigen, Yuk(a), Yuk(b), Zw alloantigen, Zw(a), Zw(b)) (Claisse et al, 1999)
CD62L (gp90-MEL, LAM-1, leukocyte adhesion molecule 1, LECAM-1, leukocyte adhesion molecule 1, Leu8, LSEL, L-selectin, selectin-L, SELL, LYAM1, MEL-14, OX85, PLNHR, TQ-1) (Borrello et al, 2005)
CD62P (GMP-140, granule membrane protein 140 kDa, GRMP, LECAM-3, leukocyte-endothelial adhesion molecule 3, PADGEM, platelet activation dependent granule-external membrane protein, PSEL, P-selectin, S12 antigen, selectin-P, SELP) (Borrello et al, 2005)
CD80 (B7, B7-1, BB1, B-lymphoblast antigen-1, Ly53) (Battifora et al, 1998; Paolieri et al, 1999; You et al, 1999)
CD146 (A32, BT14, L101, gp130 antigen, MCAM, Melanoma cell adhesion molecule, MelCAM, melanoma adhesion molecule, MUC18, P1H12, S-endo 1, Gicerin, 1-gicerin, s-gicerin) (Borrello et al, 2005)
CFLAR (Caspase-8 and FADD-like apoptosis regulator, CASH, caspase homolog, Casper, caspase eight-related protein, Caspase-8 related protein, CLARP, caspase-like apoptosis-regulatory protein, FLAME-1, FADD-like anti-apoptotic molecule-1, c-FLIP, FLIP, FLICE-inhibitory proteins, I-FLICE, Inhibitor of FLICE, MRIT, Mach-Related Inducer of Toxicity, Usurpin) (Wei et al, 2003)
Clusterin (CLU, dimeric acidic glycoprotein, DAG protein, testosterone repressed prostate message-2, TRPM-2, sulfated glycoprotein-2, SGP-2, complement-associated protein SP-40,40, SP-40,40, complement lysis inhibitor, CLI, Apolipoprotein J) (Lemansky et al, 1999)
C-type natriuretic peptide (CNP, ANP-C, NPPC, natriuretic peptide precursor type C, CNP-22, CNP-53, NPPC) receptors (Sellitti et al, 2002)
CXCL1 (CXC chemokine ligand 1, chemokine (C-X-C motif) ligand 1, SCYB1, CINC-1, Cytokine induced neutrophil chemoattractant-1, fsp, fibroblast secretory protein, GRO1, GRO-alpha, KC, MGSA, melanoma growth stimulatory activity, MGSA-alpha, melanoma growth stimulatory activity-alpha, NAP-3, neutrophil-activating protein-3, N51) (Borrello et al, 2005)
CXCL2 (CXC chemokine ligand 2, chemokine (C-X-C motif) ligand 2, CINC-2-alpha, Cytokine induced neutrophil chemoattractant-2-alpha, GRO2, growth-related oncogene-2, GRO-beta, growth regulated oncogene-beta, MIP-2-alpha, macrophage inflammatory protein-2-alpha, MGSA-beta, melanoma growth stimulatory activity-beta, SCYB2) (Borrello et al, 2005)
CXCL3 (CXC chemokine ligand 3, chemokine (C-X-C motif) ligand 3, CINC-2-beta, Cytokine induced neutrophil chemoattractant-2-beta, DCIP-1, DC inflammatory protein-1, GRO3, GRO-gamma, growth regulated oncogene-gamma, growth-related oncogene-3, MGSA-gamma, melanoma growth stimulatory activity-gamma, MIP-2-beta, macrophage inflammatory protein-2-beta) (Borrello et al, 2005)
CXCL5 (CXC chemokine ligand 5, chemokine (C-X-C motif) ligand 5, ENA-78, Epithelial neutrophil-activating protein 78, epithelial cell-derived neutrophil attractant-78, LIX, LPS induced CXC chemokine, AMCF-2, Alveolar macrophage chemotactic factor-2, SCYB5) (Borrello et al, 2005)
CXCL6 (CXC chemokine ligand 6, chemokine (C-X-C motif) ligand 6, GCP-2, granulocyte chemotactic peptide-2, CKA-3, chemokine alpha 3, SCYB6) (Borrello et al, 2005)
CXCL9 (CXC chemokine ligand 9, chemokine (C-X-C motif) ligand 9, mig, monokine induced by gamma-Interferon, Humig, Mumig, CRG-10, cytokine responsive gene-10, M119, SCYB9) (Garcia-Lopez et al, 2001; Kemp et al, 2003)
CXCL10 (CXC chemokine ligand 10, chemokine (C-X-C motif) ligand 10, IP-10, INP-10, inflammatory protein 10, Interferon-inducible protein-10, IFN-inducible protein 10, immune protein-10; 10 kDa interferon-inducible protein, gamma-IP-10, CRG-2, cytokine responsive gene-2, C7, Ifi10, interferon-inducible-10, mob-1, SCYB10) (Garcia-Lopez et al, 2001; Crescioli et al, 2007)
CXCL12 (CXC chemokine ligand 12, chemokine (C-X-C motif) ligand 12, IRH, intercrine reduced in hepatomas, hIRH, intercrine reduced in hepatomas, SDF-1-alpha, CXCL12-alpha, SDF-1-beta, CXCL12-beta, SDF, SDF-1, Stromal cell-derived factor, Stromal cell-derived factor-1-alpha, Stromal cell-derived factor-1-beta, PBSF, pre-B-cell growth stimulating factor, TLSF, Thymic lymphoma cell stimulating factor, Thymic lymphoma cell stimulating factor-alpha, Thymic lymphoma cell stimulating factor-beta, TLSF-alpha, TLSF-beta, TPAR-1, TPA repressed gene-1, SCYB12) (Borrello et al, 2005)
CXCR4 (CXC-Chemokine receptor 4, LESTR, leukocyte-derived 7-transmembrane domain receptor, HUMSTR, NPYRL, neuropeptide Y receptor-like, NPY3R, neuropeptide Y receptor Y3, HM89, Fusin, LCR-1, FB22, LAP3, Lipopolysaccharide-associated protein 3, SDF-1 receptor, CD184, AURA86, augmented in rheumatoid arthritis 86) (Borrello et al, 2005; Castellone et al, 2004)

DREAM (DRE-Antagonist Modulator, Calsenilin, Kv channel-interacting protein-3, KCHIP3, KCNIP3) (Rivas et al, 2004)

E-cadherin (epithelial cadherin, Arc-1, cadherin-1, CDH1, CAM 120/80, ECAD, L-CAM, liver cell adhesion molecule, Uvomorulin, rrl antigen, CD324) (Brabant et al, 1995)
EGF (epidermal growth factor, EGF-URO, HMGF, human milk growth factor, PGF, prostatic growth factor, beta-Urogastrone, URO, URG, Urogastrone, tooth-lid factor) receptors (EGFR, EGF receptor 1, epidermal growth factor receptor 1, erb, erbB1, HER1, SA-7, species antigen 7) (Asmis et al, 1995; Bechtner et al, 1999; Cowin et al, 1996; Grande et al, 2002; Kotlarz et al, 2002; Metcalfe et al, 1992; Tseng et al, 1989)
Egr-1 (Early growth response gene-1, ETR103, d2, zif268, NGFI-A, nerve growth factor-inducible A, Krox-24, GOS-30, G0/G1 switch gene 30, TIS8, TPA-inducible sequence-8, tetradecanoyl phorbol acetate-inducible sequence-8, ZENK, zfp6, Zinc finger protein 6) (Park et al, 2003)

FAS ligand (FASL, FASLG, APT1LG1, apoptosis antigen ligand 1, CD95 ligand, CD95L, APO-1 ligand, APTL, Apoptosis antigen ligand, TNF ligand superfamily member 6, TNFSF6, CD178) (Hiromatsu et al, 1999; Sera et al, 2001; Tamura et al, 1998; Wei et al, 2003)
ferritin (H-Ferritin, FTH1, FTH, CD-GF, carcinoma-derived growth factor) (Park et al, 2003)

Galectin-1 (Gal-1, LGALS1, galactose-specific soluble lectin 1, L-14-I, Lactose-binding lectin 1, S-lac lectin-1, Galaptin, 14 kDa beta-galactoside-binding lectin, 14 kDa lectin, HLBP14, 14 kDa laminin binding protein) (Savin et al, 2003)
Galectin-3 (Gal-3, LGALS3, galactose-specific soluble lectin 3, Mac-2, macrophage galactose-specific lectin-2, L-29, CBP-35, carbohydrate binding protein-35, IgE binding factor epsilon, Epsilon BP) (Savin et al, 2003)
galectin-3-binding protein (LGALS3BP, Mac2BP, M2BP, Mac-2-binding protein, TAA90K, Tumor-associated antigen 90K, serum protein 90K, L3 antigen, CyCAP, cyclophilin C-associated protein, alpha-2-SGP, alpha-2-seminoglycoprotein) (Grassadonia et al, 2004)
G-CSF (Granulocyte colony stimulating factor, CSF-3, colony stimulating factor-3, CSF-beta, colony stimulating factor-beta, G-CSA, granulocytic neutrophil colony stimulating activity, Pluripoietin-beta) (Borrello et al, 2005)
ghrelin (GHRL, GRLN, MTLRP, motilin-related peptide, GHSR ligand, growth hormone secretagogue receptor ligand, GGDT, ghrelin gene-derived transcript) (Volante et al, 2003)
GM-CSF (Granulocyte-macrophage colony stimulating factor, BPA, burst promoting activity, CSF-2, colony stimulating factor-2, GM-CSA, Granulocyte-macrophage colony stimulating activity, MGI-1GM, macrophage-granulocyte inducer, Pluripoietin-alpha) (Aust et al, 1996; Borrello et al, 2005; Kasai et al, 1997; Matsumara et al, 1999)

HGF (hepatocyte growth factor, HGF/SF, Hepatocyte growth factor-scatter factor, F-TCF, fibroblast tumor cytotoxic factor, HPTA, Hepatopoietin A, SF, scatter factor, TCF, tumor cytotoxic factor, Lung fibroblast-derived mitogen) receptors (met, HGFR, HGF receptor, hepatocyte growth factor receptor, scatter factor receptor) (Depoortere et al, 2000)
hsp72 (Sztankay et al, 1994)

ICAM-2 (intercellular adhesion molecule 2, Ly60, CD102) (Tandon et al, 1992)
IFN-alpha (interferon-alpha, Alpha-Interferon, aIFN, B-cell interferon, Leukocyte interferon, LeIFN, Lymphoblast interferon, LyIFN-alpha) receptors (IFNAR1, IFN-alpha/beta receptor 1, interferon (alpha, beta and omega) receptor 1, IFN-alphaR1, IFRC, IFNAR, IFNAR2, IFN-alpha/beta receptor 2, interferon (alpha, beta and omega) receptor 2, IFN-alphaR2, IFNABR) (Guerin et al, 1990; You et al, 1999; Selzer et al, 1994)
IFN-gamma (IFNG, interferon-gamma, Gamma-Interferon, gIFN) receptors (IFNGR1, IFN-gamma receptor-1, IFN-gamma-R1, interferon-gamma receptor 1, immune interferon receptor 1, AVP type 2, antiviral protein type 2, CD119, IFNGR2, interferon-gamma receptor 2, IFN-gamma receptor 2, IFN-gamma-R2, IFGR2, IFNGT1, interferon-gamma transducer 1) (Asakawa et al, 1990; Ashizawa et al, 1989; Campbell et al, 1986; Crescioli et al, 2007; Garcia-Lopez et al, 2001; Gerard et al, 2006; Goulvestre et al, 2002; Kung and Lau, 1990; Kung et al, 1992; Li et al, 2001; Nagayama et al, 1987; Sharma et al, 2005; Sztankay et al, 1994; Tedelind et al, 2003; Yu et al, 2006; Crescioli et al, 2007)
IFN-omega (Omega-Interferon, IFN-alpha II1) receptors (IFNAR1, IFN-alpha/beta receptor 1, interferon (alpha, beta and omega) receptor 1, IFN-alphaR1, IFRC, IFNAR, IFNAR2, IFN-alpha/beta receptor 2, interferon (alpha, beta and omega) receptor 2, IFN-alphaR2, IFNABR) (Selzer et al, 1994)
IGF-1 (Insulin-like growth factor-1, Erythropoietic factor, mechano growth factor, MGF, ILGF1, somatomedin C, NSILA, non-suppressible insulin-like activity, Somatomedin A, Somatomedin C, sulfation factor, Mecasermin) (Beere et al, 1995; Dawson et al, 1995; Maciel et al, 1995; Tode et al, 1989)
IGF-1 (Insulin-like growth factor-1, Erythropoietic factor, mechano growth factor, MGF, ILGF1, somatomedin C, NSILA, non-suppressible insulin-like activity, Somatomedin A, Somatomedin C, sulfation factor, Mecasermin) receptors (IGF1R, CD221, JTK13) (Backeljauw et al, 1994; Burikhanov et al, 1996; Gianoukakis et al, 2006; Liu et al, 1996; Mincione et al, 2003; Tode et al, 1989; Tominaga et al, 1994; Tramontano et al, 1987)
IGF-2 (Insulin-like growth factor-2, Growth-promoting activity for vascular endothelial cells, T3M-11-derived growth factor, ILGF2, MSA, multiplication stimulating activity, NSILA, non-suppressible insulin-like activity, Somatomedin A, sulfation factor, SGF, skeletal growth factor, HP1-SMP, HP3-SMP, Somatomedin/insulin-like growth factor-like polypeptides, C11orf43, chromosome 11 open reading frame 43) (Maciel et al, 1989)
IGF-2 (Insulin-like growth factor-2, Growth-promoting activity for vascular endothelial cells, T3M-11-derived growth factor, ILGF2, MSA, multiplication stimulating activity, NSILA, non-suppressible insulin-like activity, Somatomedin A, sulfation factor, SGF, skeletal growth factor, HP1-SMP, HP3-SMP, Somatomedin/insulin-like growth factor-like polypeptides, C11orf43, chromosome 11 open reading frame 43) receptors (IGF2R, CD222, mannose-6-phosphate receptor; MPR, CIM6PR, cation-independent mannose 6-phosphate receptor, MPRI, MPR300) (Backeljauw et al, 1994; Veneziani et al, 1992)
IGFBP2 (Insulin-like growth factor binding protein-2, IGF binding protein-2) (Wang et al, 1991)
IGFBP3 (Insulin-like growth factor binding protein-3, IGF binding protein-3, BP-53, Growth hormone dependent binding protein, Binding protein-29) (Wang et al, 1991)
IGFBP5 (Insulin-like growth factor binding protein-5, IGF binding protein-5) (Backeljauw et al, 1994)
IL1-alpha (IL1A, interleukin-1-alpha, IL1F1, Interleukin-1 family member 1, BAF, B-cell activating factor, BCAF, B-cell activating factor, EP, endogenous pyrogens, LAF, lymphocyte activating factor, LEM, leukocyte endogenous mediator, MCF, mononuclear cell factor, MNCF, mononuclear cell factor, MP, mitogenic protein, TRF-3, T-cell replacing factor-3, Tumor inhibitory factor-2) (Borrello et al, 2005; Grubeck-Loebenstein et al, 1989; Watson et al, 1995; Zheng et al, 1991)
IL1-alpha (IL1A, interleukin-1-alpha, IL1F1, Interleukin-1 family member 1, BAF, B-cell activating factor, BCAF, B-cell activating factor, EP, endogenous pyrogens, LAF, lymphocyte activating factor, LEM, leukocyte endogenous mediator, MCF, mononuclear cell factor, MNCF, mononuclear cell factor, MP, mitogenic protein, TRF-3, T-cell replacing factor-3, Tumor inhibitory factor-2) receptors (IL1RA, IL1R-alpha, IL1 receptor-alpha; interleukin-1 receptor-alpha, IL1R1, IL1 receptor type 1, Interleukin-1 receptor 1, IL1 receptor R1, CD121a; IL1RB, IL1R-beta, IL1 receptor-beta; interleukin-1 receptor-beta, IL1R2, IL1 receptor type 2, Interleukin-1 receptor 2, IL1 receptor R2, CD121b, AURA31, augmented in rheumatoid arthritis 31) (van den Hove et al, 2002)
IL1-beta (IL1B, interleukin-1-beta, IL1F2, Interleukin-1 family member 2, Catabolin, H1, Hematopoietin-1, IFN-beta inducing factor, Interleukin-beta, OAF, osteoclast activating factor) (Borrello et al, 2005; Paolieri et al, 1999)
IL1-beta (IL1B, interleukin-1-beta, IL1F2, Interleukin-1 family member 2, Catabolin, H1, Hematopoietin-1, IFN-beta inducing factor, Interleukin-beta, OAF, osteoclast activating factor) receptors (IL1RA, IL1R-alpha, IL1 receptor-alpha; interleukin-1 receptor-alpha, IL1R1, IL1 receptor type 1, Interleukin-1 receptor 1, IL1 receptor R1, CD121a; IL1RB, IL1R-beta, IL1 receptor-beta; interleukin-1 receptor-beta, IL1R2, IL1 receptor type 2, Interleukin-1 receptor 2, IL1 receptor R2, CD121b, AURA31, augmented in rheumatoid arthritis 31) (Goulvestre et al, 2002; Mezosi et al, 2004; Nilsson et al, 1998; Rasmussen et al, 1990)
IL1 (interleukin-1) receptors (IL1RA, IL1R-alpha, IL1 receptor-alpha; interleukin-1 receptor-alpha, IL1R1, IL1 receptor type 1, Interleukin-1 receptor 1, IL1 receptor R1, CD121a; IL1RB, IL1R-beta, IL1 receptor-beta; interleukin-1 receptor-beta, IL1R2, IL1 receptor type 2, Interleukin-1 receptor 2, IL1 receptor R2, CD121b, AURA31, augmented in rheumatoid arthritis 31) (Diamant et al, 1991; Gerard et al, 2006; Kasai et al, 1996; Mine et al, 1987)
IL4 (Interleukin-4, BCDF-epsilon, B-cell differentiation factor-epsilon, BCDF-gamma, B-cell differentiation factor-gamma, BCGF-gamma, B-cell growth factor-gamma, BCGF-1, B-cell growth factor-1, Binetrakin, BSF-1, B-cell stimulating factor-1, BSF-p1, B-cell stimulating factor p1, EL4-BCGF, EL4 B-cell growth factor, HCGF, Hodgkin's cell growth factor, IgE-EF, IgE enhancing factor, IgG1-enhancing factor, IgG1-induction factor, LMW-BCGF, low molecular weight B-cell growth factor, MaGEF, Mast cell growth enhancing factor, MCGF-2, mast cell growth factor-2, MFF, macrophage fusion factor, Pitrakinra, TCGF-2, T-cell growth factor-2) receptors (IL4RA, IL4R-alpha, interleukin-4 receptor-alpha, IL4R, interleukin-4 receptor, CD124) (Li et al, 2001)
IL6 (interleukin-6, 26 kDa protein, BSF-2, B-cell stimulating factor-2, CDF, CAT development factor, choline acetyltransferase development factor, Cytolytic differentiation factor for T-lymphocytes, FDGI, fibroblast-derived growth inhibitor, hybridoma growth factor, HPGF, hybridoma/plasmacytoma growth factor, HSF, hepatocyte stimulating factor, HSF-1, hepatocyte stimulating factor-1, ILHP1, Interleukin-hemopoietin-1, MGI-2A, Macrophage-granulocyte inducer-2A, Myeloma GF, myeloma growth factor, NKAF, natural killer cell activating factor, TAF, T-cell activating factor, Thymocyte growth factor, TSF, thymocyte stimulating factor) (Caraccio et al, 2005; Diamant et al, 1991; Grubeck-Loebenstein et al, 1989; Iwamoto et al, 1991; Jones et al, 1997; Nakajima et al, 2001; Watson et al, 1995; Weetman et al, 1990; Zheng et al, 1991)
IL6 (interleukin-6, 26 kDa protein, BSF-2, B-cell stimulating factor-2, CDF, CAT development factor, choline acetyltransferase development factor, Cytolytic differentiation factor for T-lymphocytes, FDGI, fibroblast-derived growth inhibitor, hybridoma growth factor, HPGF, hybridoma/plasmacytoma growth factor, HSF, hepatocyte stimulating factor, HSF-1, hepatocyte stimulating factor-1, ILHP1, Interleukin-hemopoietin-1, MGI-2A, Macrophage-granulocyte inducer-2A, Myeloma GF, myeloma growth factor, NKAF, natural killer cell activating factor, TAF, T-cell activating factor, Thymocyte growth factor, TSF, thymocyte stimulating factor) receptors (IL6RA, IL6R-alpha, IL6R, interleukin-6 receptor, interleukin-6 receptor-alpha, CD126, IL6ST, IL6 signal transducer, interleukin-6 signal transducer, IL6R-beta, interleukin-6 receptor-beta, IL6RB, CDw130, CD130) (Matsumara et al, 1999)
IL8 (interleukin-8, SCYB8, 3-10C, 9E3, ANAP, anionic neutrophil-activating peptide, Chemotaxin, CEF-4, CT/IL8, CXCL8, CXC chemokine ligand 8, chemokine (C-X-C motif) ligand 8, EDNAP, endothelial-derived neutrophil-activating peptide, EMF-1, embryo fibroblast protein 1, Emoctakin, ENAP, Endothelial cell neutrophil-activating peptide, FDNAP, Fibroblast-derived neutrophil-activating peptide, FINAP, fibroblast-derived neutrophil-activating protein, GCF, granulocyte chemotactic factor, GCP, granulocyte chemotactic peptide, LAI, leukocyte adhesion inhibitor, LCF, lymphocyte chemotactic factors, LDNAP, leukocyte-derived neutrophil-activating peptide, leukocyte inhibitory factor, LUCT, lung carcinoma-derived chemotaxin, LYNAP, lymphocyte-derived neutrophil-activating peptide, MDNAP, monocyte-derived neutrophil-activating peptide, MDNCF, monocyte-derived neutrophil chemotactic factor, MOC, monocyte-derived chemotaxin, MONAP, monocyte-derived neutrophil-activating peptide, NAF, neutrophil-activating factor, NAP-1, neutrophil-activating protein-1, NCF, neutrophil chemotactic factor, NCP, neutrophil chemotactic protein, PLF, psoriatic leukotactic factor, TCF, T-cell chemotactic factor, TSG-1, Tumor necrosis factor-stimulated gene sequence-1) (Borrello et al, 2005; Watson et al, 1995; Weetman et al, 1992)
IL10 (interleukin-10, B-TCGF, B-cell derived T-cell growth factor, CSIF, cytokine synthesis inhibitory factor, TGIF, T-cell growth inhibitory factor) receptors (IL10R, IL10R1, IL10RA, IL10 receptor-alpha, IL10R-alpha, interleukin-10 receptor-alpha; interleukin-10 receptor, CD210, CD210a, CDw210a; IL10R2, IL10RB, IL10R-beta, IL10 receptor-beta, interleukin-10 receptor-beta, CRF2-4, cytokine receptor family 2 member 4, CRFB4; CDw210b) (Goulvestre et al, 2002)
IL16 (Interleukin-16, Lymphocyte chemoattractant factor, LCF) (Gianoukakis et al, 2006)

M-CSF (macrophage colony stimulating factor, CSF-1, colony stimulating factor-1, CSF-HU, Urinary colony stimulating factor, MGF, macrophage growth factor, MGI-1M, macrophage-granulocyte inducer, op, osteopetrotic, toothless, tl, Lanimostim) (Borrello et al, 2005; Kasai et al, 1997; Matsumara et al, 1999)
MMP-1 (matrix metalloproteinase-1, collagenase, collagenase-1, CL-1, CLG1, fibroblast collagenase, fibroblast-type collagenase, interstitial collagenase, tissue collagenase, EC3.4.23.7) (Aust et al, 1997; Borrello et al, 2005)
MMP-2 (matrix metalloproteinase-2, EC3.4.24.24, 70 kDa gelatinase, 72 kDa gelatinase, 72 kDa metalloproteinase, collagenase type 4, collagenase type 4A, 72 kDa type IV collagenase, Gelatinase 72 kDa, Gelatinase A, Type IV collagenase, Type IVA collagenase, neutrophil gelatinase) (Borrello et al, 2005)
MMP-3 (matrix metalloproteinase-3, stromelysin-1, STMY1, STR1, SL-1, transin, transin-1, collagenase activating protein, procollagenase activator, proteoglycanase) (Borrello et al, 2005)
MMP-7 (matrix metalloproteinase-7, matrilysin, Matrilysin-1, PUMP, punctuated metalloproteinase, pump-1, putative metalloproteinase-1, matrin, EC3.4.24.23) (Borrello et al, 2005)
MMP-9 (matrix metalloproteinase-9, EC3.4.24.35, gelatinase B, 92 kDa gelatinase, 92 kDa type IV collagenase, or PMNL gelatinase, polymorphonuclear leukocyte gelatinase, gelatinase type IV-B, collagenase type 5, collagenase-5, CL-5) (Borrello et al, 2005)
MMP-10 (matrix metalloproteinase-10, stromelysin-2, STMY2, SL-2, ST-2, transin-2, EC3.4.24.22) (Borrello et al, 2005)
MMP-14 (matrix metalloproteinase-14, MT1-MMP, Membrane-type matrix metalloproteinase-1, MT-MMP-1, MMP-X1) (Borrello et al, 2005)

NIPK [Neuronal cell death-inducible putative kinase] (Park et al, 2003)
nm23 (nonmetastatic gene 23, p19/nm23, EC2.7.4.6, NDP kinase, nucleoside diphosphate kinase, NDP kinase A, NDPKA, Nucleoside diphosphate kinase A, nm23A, NDP kinase B, NDPKB, Nucleoside diphosphate kinase B, nm23B, NME1, nonmetastatic cells 1, NME2, nonmetastatic cells 2, Metastasis inhibition factor, nm23-H1, GADD, Granzyme A-activated DNase, I factor, PuF, nm23-H2) (Luo et al, 1993)
NR-CAM [neuronal cell adhesion molecule] (Borrello et al, 2005)
nur-77 (nuclear receptor-77, NAK1, NGFI-B, nerve growth factor-inducible B, RNR-1, regenerating liver nuclear receptor, NR4A1, nuclear receptor subfamily 4 group A member 1, TIS1, TPA-inducible sequence-1, tetradecanoyl phorbol acetate-inducible sequence-1) (Jimenez-Cervantes et al, 1998)

osteopontin (OPN, OP, Osp, 2ar, 44 kDa bone phosphoprotein, 66 kDa bone phosphoprotein, bone sialoprotein, bone sialoprotein-1, BSP, BSP1, BSPI, Calcium oxalate crystal growth inhibitor protein, Eta-1, early T-lymphocyte activation protein 1, Nephropontin, Spp-1, Secreted Phosphoprotein-1, transformation-related phosphoprotein, tumor-secreted phosphoprotein, urinary stone protein, Uropontin) (Borrello et al, 2005)
osteoprotegerin (OPG, FDCR-1, FDC-derived receptor-1, OCIF, osteoclastogenesis inhibitory factor, OCIF/OPG, OPG/OCIF, TNFRSF11B, TNF receptor superfamily member 11B, TR1, TNF receptor-like-1) (Hofbauer et al, 2002)

PAI-1 (Plasminogen activator inhibitor-1, PAI, plasminogen activator inhibitor, endothelial plasminogen activator inhibitor, Serpin E1, MSF, monocyte suppressor factor, EIP-1, EGF-inducible protein 1, mesosecrin) (Kotlarz et al, 2002; Borrello et al, 2005)
PlGF (placenta growth factor, Placental growth factor, PGF, PlGF-1, placenta growth factor-1, PlGF-2, placenta growth factor-2) (Viglietto et al, 1997)
PlGF (placenta growth factor, Placental growth factor, PGF, PlGF-1, placenta growth factor-1, PlGF-2, placenta growth factor-2) receptors (Viglietto et al, 1997)
prion protein (PRP, PRNP, PrPc, CD230) (Yamazaki et al, 2003)
prolactin (PRL, lactogenic hormone, lactotropin, lactotropic hormone, mammotropin, mammotropic hormone, luteotropic hormone, LTH, luteotropin) receptors (PRLR) (Li et al, 2001; You et al, 1999)

RANKL (RANK ligand, receptor activator of NF-kappa-B ligand, ODF, Osteoclast differentiation factor, OPGL, Osteoprotegerin ligand, SOFA, Stromal osteoclast-forming activity, TRANCE, tumor necrosis factor-related activation induced cytokine, TNFSF11, TNF ligand superfamily member 11) (Hofbauer et al, 2002)
relaxin-like factor (RLF, Leydig cell insulin-like factor, Ley-I-L, Insulin-like-3, INSL3) (Hombach-Klonisch et al, 2003)

S100 (S100a, S100A1, S100-alpha, S100b, S100-beta, NEF, neurite extension factor) (Vanstapel et al, 1986; Nishimura et al, 1997)
somatostatin (SST, Somatotropin release inhibiting hormone, SIH, Somatotropin release inhibiting factor, SRIF, growth hormone-inhibiting hormone, GIH, growth hormone release inhibitory hormone, GH-RIH) receptors (Tsuzaki and Moses, 1990; Zerek-Melen et al, 1990)

TGF-beta-1 (TGFB1, transforming growth factor-beta-1, CIF-A, cartilage inducing factor A, ISF, immunosuppressive factor, MGF-b, milk growth factor, PDGI, platelet-derived endothelial cell growth inhibitor) (Cowin and Bidet, 1995; Cowin et al, 1996)
TGF-beta-1 (TGFB1, transforming growth factor-beta-1, CIF-A, cartilage inducing factor A, ISF, immunosuppressive factor, MGF-b, milk growth factor, PDGI, platelet-derived endothelial cell growth inhibitor) receptors (TGFBR1, TbetaRI, TbetaR1, transforming growth factor-beta receptor 1, TGF-beta receptor 1; TGF-beta receptor type 1, type 1 TGF-beta receptors, ALK5, Activin receptor-like kinase 5, activin A receptor type 2-like kinase, ACVRLK4, activin receptor-like kinase 4 ; TGFBR2, TbetaRII, TbetaR2, transforming growth factor-beta receptor 2, TGF-beta receptor 2, TGF-beta receptor type 2, type 1 TGF-beta receptors, MFS2, Marfan syndrome type 2) (Bechtner et al, 1999; Cowin et al, 1996; Depoortere et al, 2000; Kotlarz et al, 2002; Liu et al, 1996; Mincione et al, 2003; Napolitano et al, 2000)
TGF-beta (transforming growth factor-beta, TGFB, B-TGF, Aqueous humor lymphocyte inhibitory activity, DIF, differentiation-inhibiting factor, EGI, epithelial cell-specific growth inhibitor; epithelial growth inhibitor, EIF, Epstein-Barr virus inducing factor, Epithelial cell growth inhibiting factor, G-TsF, glioma-derived T-cell suppressor factor, MDGF, milk-derived growth factor, MGF, milk growth factor, Polyergin, Simian BSC-1 cell growth inhibitor, SP factor, TCGF, transformed cell growth factor, TGI, tissue-derived growth inhibitor, TIF-1, tumor inducing factor-1) receptors (TGFBR1, TbetaRI, TbetaR1, transforming growth factor-beta receptor 1, TGF-beta receptor 1; TGF-beta receptor type 1, type 1 TGF-beta receptors, ALK5, Activin receptor-like kinase 5, activin A receptor type 2-like kinase, ACVRLK4, activin receptor-like kinase 4 ; TGFBR2, TbetaRII, TbetaR2, transforming growth factor-beta receptor 2, TGF-beta receptor 2, TGF-beta receptor type 2, type 1 TGF-beta receptors, MFS2, Marfan syndrome type 2) (Bravo et al, 2003; Grande et al, 2002; Matsumara et al, 1999; Toda et al, 1997)
thioredoxin (TRX, TRX1, thioredoxin-1, TRX80, BSF-MP6, B-cell stimulating factor MP6, ADF, adult T-cell leukemia-derived factor) (Kihara et al, 2005)
Thrombospondin-1 (Thrombospondin, TSP1, TSP, THBS1) (Claisse et al, 1999; Pellerin et al, 1999)
Thrombospondin-1 (Thrombospondin, TSP1, TSP, THBS1) receptors (Claisse et al, 1999; Pellerin et al, 1999)
Thymosin-beta-10 (TMSB10, Tbeta-10, Tb10, PTMB10, THYB10) (Viglietto et al, 1999)
Thyrotropin (TSH, thyroid stimulating hormone, Thyrotropic hormone) receptors (Banu et al, 2001; Frohlich et al, 2004; Kawakami et al, 1996; Yamazaki et al, 2003)
TIMP-1 (tissue inhibitor of metalloproteinases-1, TIMP metallopeptidase inhibitor 1, TIMP, tissue inhibitor of metalloproteinases, HCI, human collagenase inhibitor, CLGI, 3/10, 16C8, Fibroblast elongation factor, fibroblast collagenase inhibitor, B1 anticollagenase, Beta-1 anticollagenase, EPA, erythroid promoting activity, embryogenin-1, TPA-S1, TPA-induced protein S1) (Aust et al, 1997)
TIMP-2 (tissue inhibitor of metalloproteinases-2, TIMP metallopeptidase inhibitor 2, CSC-21K, MI, CHIAMP, Chondrocyte-derived inhibitor of angiogenesis and metalloproteinase activity) (Borrello et al, 2005)
TIMP-3 (tissue inhibitor of metalloproteinases-3, TIMP metallopeptidase inhibitor 3, mitogen-inducible gene 5, mig-5; SFD, Sorsby fundus dystrophy) (Borrello et al, 2005)
TLR-3 (Toll-like receptor-3, CD283) (Harii et al, 2005)
TNF-alpha (tumor necrosis factor-alpha, TNFSF2, TNF ligand superfamily member 2, Cachectin, CF, cytotoxic factor, CTX, cytotoxin, DIF, differentiation inducing factor, EP, endogenous pyrogens, Hemorrhagic factor, Macrophage-derived cytotoxic factor, J774-derived cytotoxic factor, MCF, macrophage cytotoxic factor, MCT, macrophage cytotoxin, MD-FGF, monocyte-derived fibroblast growth factor, PCF, peritoneal cytotoxic factor, RCF, Released cytotoxic factor) (Mori et al, 2005)
TNF-alpha receptor type 1) (secreted) (soluble CD120a) (LaBue et al, 2004)
TNF-alpha (tumor necrosis factor-alpha, TNFSF2, TNF ligand superfamily member 2, Cachectin, CF, cytotoxic factor, CTX, cytotoxin, DIF, differentiation inducing factor, EP, endogenous pyrogens, Hemorrhagic factor, Macrophage-derived cytotoxic factor, J774-derived cytotoxic factor, MCF, macrophage cytotoxic factor, MCT, macrophage cytotoxin, MD-FGF, monocyte-derived fibroblast growth factor, PCF, peritoneal cytotoxic factor, RCF, Released cytotoxic factor) receptors (CD120a, TNFRSF1A, TNF receptor superfamily member 1A, FPF, TNFAR, TNFR, TNFR1, TNFR55, TNFR60, TNFR-alpha, TNF receptor 1; CD120b, TNFRSF1B, TNF receptor superfamily member 1B, p75TNFR, TNFR2, TNFR75, TNFR80, TNFR-beta) (Crescioli et al, 2007; Garcia-Lopez et al, 2001; Kasai et al, 1996; Goulvestre et al, 2002; Mezosi et al, 2004; Mori et al, 2005; Taverne et al, 1987; Crescioli et al, 2007)
TRAIL (TNF-related apoptosis inducing ligand, APO-2 ligand, APO-2L, TL2, TNF-like-2, TNF ligand superfamily member 10, TNFSF10, Ly81, CD253) receptors (Bretz et al, 1999, 2002; Mezosi et al, 2004)
transferrin (TRF, DF-77, GPBP, granulocyte/pollen-binding protein, Lung-derived growth factor) receptors (CD71, TFR, TFR1, TRFR, TFRC, OKT9, T9, OX26) (Lombardi et al, 1989)

VEGF-A (Vascular endothelial growth factor A; VEGF-1, vascular endothelial growth factor-1, VEGF, vascular endothelial growth factor; vasculo-endothelial growth factor, VEG/PF, vascular endothelial growth factor/vascular permeability factor, GD-VEGF, glioma-derived vascular endothelial growth factor, VAS, Vasculotropin, Vascular endothelial cell proliferation factor; VPF, vascular permeability factor, Mouse sarcoma 180-derived growth factor; FSdGF, Folliculo stellate cell-derived growth factor) (Kihara et al, 2005; Viglietto et al, 1997; Wang et al, 1998)
VEGF-A (Vascular endothelial growth factor A; VEGF-1, vascular endothelial growth factor-1, VEGF, vascular endothelial growth factor; vasculo-endothelial growth factor, VEG/PF, vascular endothelial growth factor/vascular permeability factor, GD-VEGF, glioma-derived vascular endothelial growth factor, VAS, Vasculotropin, Vascular endothelial cell proliferation factor; VPF, vascular permeability factor, Mouse sarcoma 180-derived growth factor; FSdGF, Folliculo stellate cell-derived growth factor) receptors (Viglietto et al, 1997; Wang et al, 1998)
VIP (vasoactive intestinal peptide) receptors (Harmar et al, 2004)

For related information of interest see also: Cell types, Cell lines in Cytokine Research, Cell culture.


Copyright 2012 by H IBELGAUFTS. All rights reserved.
ENTRY LAST MODIFIED: December 2008



 

See REFERENCES for entry thyrocytes.

Click BACKLINKS to see which COPE entries contain the term thyrocytes .




COPE Homepage Top of Page


 
 
SUPPORT COPE | Santa Claus | Intro | Subdictionaries | New Entries | Contribute data | COPE Credentials
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Please inquire. COPE is looking for long-term support from a company appreciating and committed to communication biology

              Created, developed, and maintained by Prof Dr H Ibelgaufts              
About the author of COPE
  |    Contact COPE   |    postcard and stampware   |    Terms & Conditions


Access to COPE is free only for academic institutions and non-profit organizations.
OTHER USERS: must contact COPE and pay a site licence fee.

U L T R A   P O S S E   N E M O   O B L I G A T U R